Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
36.50
USD
-0.23 (-0.63%)
Official Closing Price
Updated: 5:37 PM EST, Jan 20, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Psychedelics Could Become the Next Health and Wellness Trend
October 20, 2020
FN Media Group Presents Microsmallcap.com Market Commentary
From
PR Newswire
Psychedelics Could Become the Next Health and Wellness Trend
October 20, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Should you invest in Nio Inc, Nikola Corp, Pfizer, Snap, or Flex?
October 19, 2020
InvestorsObserver issues critical PriceWatch Alerts for NIO, NKLA, PFE, SNAP, and FLEX.
From
PR Newswire
2nd Annual Gabelli Funds – Columbia Business School Healthcare Symposium (Virtual)
October 19, 2020
Join us as we discuss today’s pressing healthcare issues.
From
Business Wire News Releases
Transgene: Acceptance of Late Breaking Abstract at Upcoming SITC 2020 Conference, on The Detailed Results From Clinical Study of TG4001 in Combination With Avelumab in Advanced HPV-positive Cancers
October 19, 2020
Regulatory News:
From
Business Wire News Releases
Should you invest in Pfizer, Autodesk, Caterpillar, Vipshop Holdings, or JinkoSolar?
October 16, 2020
InvestorsObserver issues critical PriceWatch Alerts for PFE, ADSK, CAT, VIPS, and JKS.
From
PR Newswire
ViiV Healthcare receives positive CHMP opinion for long-acting regimen for the treatment of HIV
October 16, 2020
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the Committee for Medicinal Products for Human Use...
From
Business Wire News Releases
Orphan Drugs Market 2020 | Global Industry Overview, Sales Revenue, Demand and Opportunity 2025
October 15, 2020
Tags
Health & Medicine
From
AB Newswire
iBio Announces Appointment of Dr. Linda Armstrong to Board of Directors
October 14, 2020
From
GlobeNewswire News Releases
Targeted Therapies for Glioblastoma Becoming Critical As Increasing Incidence of Brain Cancer Rises
October 13, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Targeted Therapies for Glioblastoma Becoming Critical As Increasing Incidence of Brain Cancer Rises
October 13, 2020
Financialnewsmedia.com News Commentary
From
PR Newswire
CStone Announces Completion of $200 million Share Sale to Pfizer
October 11, 2020
- Share sale brings into effect strategic collaboration agreement
From
PR Newswire
PENELOPE-B Trial of IBRANCE® (palbociclib) in Early Breast Cancer Did Not Meet Primary Endpoint
October 09, 2020
The German Breast Group (GBG) and Pfizer Inc. (NYSE: PFE) today announced that the collaborative Phase 3 PENELOPE-B trial did not meet the primary endpoint of improved invasive disease-free survival...
From
Business Wire News Releases
New Report Projects Immunotherapy Drug Market to Reach $274.6 Billion by 2025 with CAGR of 11.0%
October 08, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
New Report Projects Immunotherapy Drug Market to Reach $274.6 Billion by 2025 with CAGR of 11.0%
October 08, 2020
- FN Media Group Presents USA News Group News Commentary
From
PR Newswire
Pfizer Announces Positive Phase 3 Top-line Results for Once-Weekly Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency
October 08, 2020
Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that C0311002, a Phase 3, randomized, multicenter, open-label, crossover study evaluating somatrogon dosed once-weekly in...
From
Business Wire News Releases
Pfizer and Sangamo Dose First Participant in Phase 3 Study Evaluating Hemophilia A Gene Therapy Treatment
October 07, 2020
Pfizer Inc. (NYSE: PFE) and Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today announced that the first participant has been dosed in the Phase 3 AFFINE study of...
From
Business Wire News Releases
Exact Sciences and Pfizer Extend and Amend Cologuard® Promotion Agreement
October 07, 2020
Successful collaboration will continue to support Cologuard adoption through 2022
From
PR Newswire
Catalio Capital Management LP Closes Oversubscribed Venture Fund II at $100 Million Hard Cap
October 06, 2020
Catalio Capital Management LP (Catalio), a prominent life sciences investment firm, announced today the close of its second venture fund, Catalio Nexus II. The fund was oversubscribed and closed at its...
From
Business Wire News Releases
BioNTech and Pfizer Initiate Rolling Submission to European Medicines Agency for SARS-CoV-2 Vaccine Candidate BNT162b2
October 06, 2020
From
GlobeNewswire News Releases
SpringWorks Therapeutics Announces Clinical Collaboration with Pfizer Inc. to Evaluate Nirogacestat in Combination with PF‐06863135 in Patients with Relapsed or Refractory Multiple Myeloma
October 05, 2020
Fifth industry collaboration to evaluate nirogacestat as a BCMA potentiator across modalities
From
GlobeNewswire News Releases
ViiV Healthcare presents a new podcast about the Power of Being Seen
October 01, 2020
Ten-episode series available October 6th features conversations with leading cultural figures and influencers discussing how Black gay and queer men want to be seen
From
PR Newswire
Pfizer Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Investigational Gene Therapy
October 01, 2020
Pfizer Inc. (NYSE: PFE) today announced that its investigational gene therapy candidate (PF-06939926) being developed to treat Duchenne muscular dystrophy (DMD) received Fast Track designation from the...
From
Business Wire News Releases
CStone, Pfizer Enter into Strategic Collaboration to Address Oncological Needs in China
September 29, 2020
CStone Pharmaceuticals (“CStone”, HKEX: 2616)] and Pfizer Investment Co. Ltd. ("Pfizer Investment") and Pfizer Corporation Hong Kong Limited ("Pfizer Hong Kong") (both of which are subsidiaries of...
From
Business Wire News Releases
U.S. FDA Approves Pfizer’s XELJANZ® (tofacitinib) for the Treatment of Active Polyarticular Course Juvenile Idiopathic Arthritis
September 28, 2020
Pfizer Inc. (NYSE: PFE) announced today that the United States (U.S.) Food and Drug Administration (FDA) approved XELJANZ® (tofacitinib) for the treatment of children and adolescents 2 years and older...
From
Business Wire News Releases
Improving Diagnostic Devices Expand Patient Monitoring Capabilities
September 25, 2020
FinancialBuzz.com News Commentary
From
PR Newswire
Pfizer Declares Fourth-Quarter 2020 Dividend
September 24, 2020
The board of directors of Pfizer Inc. (NYSE:PFE) declared a 38-cent fourth-quarter 2020 dividend on the company’s common stock, payable December 1, 2020, to holders of the Common Stock of record at the...
From
Business Wire News Releases
IDEAYA and Pfizer Expand Clinical Trial Collaboration and Supply Agreement to Evaluate Clinical Combination of IDE196 and Crizotinib in Solid Tumors Harboring GNAQ or GNA11 Mutations
September 24, 2020
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, today announced that it has...
From
PR Newswire
Javelin Biotech Aims to Develop Industry-Leading “Organ-on-a-Chip” Predictive Pharmacokinetics Platform in Collaboration with Pfizer Inc.
September 23, 2020
Javelin Biotech today announces a 3-year collaboration with Pfizer to design and build a platform to evaluate ADME properties of small molecule drugs.
From
Business Wire News Releases
ViiV Healthcare Announces Availability of CABENUVA and VOCABRIA in Canada
September 23, 2020
From
PR Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.